Emmanuel Darcq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Emmanuel Darcq has a total of 281 co-authors. Here are the top co-authors by number of shared publications:
- Brigitte Lina Kieffer
Université de Strasbourg
28 shared publications Brigitte L. Kieffer
Université de Strasbourg (UNISTRA), INSERM UMR-S 1329, Strasbourg Translational Neuroscience and Psychiatry, Centre de Recherche en Biomédecine de Strasbourg, France
9 shared publicationsSami Ben Hamida
INSERM UMR 1247 University of Picardie Jules Verne Amiens France
8 shared publicationsAliza T. Ehrlich
Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA
7 shared publications- Laura-Adela Harsan
Department of Radiology, Medical Physics, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
7 shared publications - Dorit Ron
Alcohol and Addiction Research Group, Department of Neurology, University of California, San Francisco
6 shared publications
Latest Publications
- 11 November 2026
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 46 (45)
Mu-Opioid Receptor in Habenula Circuits as a Substrate for Psychiatric Disorders and Addiction
The habenula is a critical regulator of affect, negative reinforcement, avoidance, and coping behavior. It is thus unsurprising that accumulating evidence supports pivotal roles for habenular circuits in the expression of major psychiatric illnesses including depression and addiction. Though high levels of mu-opioid receptors (MORs) were identified in the habenula more than a generation ago, the functional effects of MORs on habenular circuits remained largely unexplored due to challenges of selectively targeting this small and heterogeneous brain structure. In this SfN mini-symposium report, we highlight studies that resolve how MOR is distributed across medial and lateral habenular subnuclei and how MOR expression maps onto molecularly defined habenular cell types. We further describe some of the habenula-intersecting circuits that express MORs and how MOR signaling modulates neural activity and neurotransmission within these unique habenular circuits and cell types. Going beyond cellular-level effects of MOR signaling, we illustrate how neural activity in the habenula can influence affect and behaviors associated with opioid analgesia, opioid seeking, opioid dependence, and opioid withdrawal. Drawing on works outside the opioid field, we suggest commonalities through which drugs of abuse may influence habenula circuits to induce states of negative affect that contribute to continued drug use or relapse. Finally, we discuss how better understanding the molecular and functional properties of habenular cell types and circuits can identify new druggable targets, such as the orphan receptors GPR151 and GPR139, for the treatment of pain, mood disorders, or opioid and other substance use disorders.
- 11 November 2026
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 46 (45)
Mu-Opioid Receptor in Habenula Circuits as a Substrate for Psychiatric Disorders and Addiction
The habenula is a critical regulator of affect, negative reinforcement, avoidance, and coping behavior. It is thus unsurprising that accumulating evidence supports pivotal roles for habenular circuits in the expression of major psychiatric illnesses including depression and addiction. Though high levels of mu-opioid receptors (MORs) were identified in the habenula more than a generation ago, the functional effects of MORs on habenular circuits remained largely unexplored due to challenges of selectively targeting this small and heterogeneous brain structure. In this SfN mini-symposium report, we highlight studies that resolve how MOR is distributed across medial and lateral habenular subnuclei and how MOR expression maps onto molecularly defined habenular cell types. We further describe some of the habenula-intersecting circuits that express MORs and how MOR signaling modulates neural activity and neurotransmission within these unique habenular circuits and cell types. Going beyond cellular-level effects of MOR signaling, we illustrate how neural activity in the habenula can influence affect and behaviors associated with opioid analgesia, opioid seeking, opioid dependence, and opioid withdrawal. Drawing on works outside the opioid field, we suggest commonalities through which drugs of abuse may influence habenula circuits to induce states of negative affect that contribute to continued drug use or relapse. Finally, we discuss how better understanding the molecular and functional properties of habenular cell types and circuits can identify new druggable targets, such as the orphan receptors GPR151 and GPR139, for the treatment of pain, mood disorders, or opioid and other substance use disorders.
- 27 October 2026
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 266
Vitamin D and mental health: a translational focus on substance use, mood and anxiety disorders
- 27 October 2026
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 266
Vitamin D and mental health: a translational focus on substance use, mood and anxiety disorders
- Open Access
- 19 October 2026
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 20, 2009605
Editorial: Rethinking addiction: technological advances, mechanistic insights, and the re-evaluation of substance use disorders
Addiction research has entered an era of rapid conceptual advances seeded by recent methodological 13These advances have the field of addiction neuroscience from broad descriptions 14 of altered reward processing toward increasingly granular accounts of the circuits, cellular populations, 15 molecular mechanisms, and behavioral processes that underwrite substance use disorders (SUDs) 16 (Venniro et al., 2020;Mathis et al., 2025a;Nestler, 2025). At the same time, the concept of addiction 17 itself has expanded from an exclusive focus on impact of psychotropic drugs to encapsulating 18 problematic behavioral patterns like gambling, sex, screen time, and food intake. This expansion raises 19 many important questions, including: What exactly defines addiction? Do all forms of addiction stem 20 of pathological patterns of activity within overlapping, or distinct, brain circuit mechanisms? This 21Research Topic was conceived at the intersection of these developments. As highlighted by the studies included in this special issue, new vistas in addiction research require the 77 field move beyond emphasizing effects on singular behavioral and neural endpoints. Food and drugs, 78 for example, engage overlapping motivational systems, but feeding is also embedded within metabolic 79 regulation and physiological homeostasis. Therefore, problematic eating behaviors necessarily 80 manifest in a manner that will have overlapping, and unique, behavioral and mechanistic underpinnings 81 relative to psychoactive drugs. It's important to acknowledge these domain specific nuances, as well 82 as that not every reward-based behavior necessarily leads to addiction. Indeed, true progress will likely 83 require a greater, field-wide acknowledgement of the complex interplay of environmental, cognitive, 84 neurochemical, and genetic predispositions that seed addiction in certain individuals. 85 86The contributions to this Research Topic highlight three complementary shifts that are increasingly 87 shaping addiction research: from static measures to dynamic trajectories, from isolated brain circuits 88 to interacting biological systems, and from substance-centered definitions to mechanistically informed 89 models of maladaptive behavior. 90 91The future of addiction research will not be defined solely by our ability to measure more molecules, 92 record more neurons, or quantify more behavioral dimensions. Its progress will depend on our ability 93 to use these technologies to ask better questions and improve our analysis and interpretation. 94Rethinking addiction therefore does not necessarily mean expanding its definition. It may instead mean 95 refining it: identifying when, why, and for whom a behavior becomes persistent, maladaptive, and 96 difficult to control. This conceptual refinement, supported by increasingly sophisticated technologies 97 and integrative approaches, may ultimately provide a stronger foundation for more precise diagnosis, 98 prevention, and treatment.
- 19 October 2026
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 20, 2009605
Open AccessEditorial: Rethinking addiction: technological advances, mechanistic insights, and the re-evaluation of substance use disorders
Addiction research has entered an era of rapid conceptual advances seeded by recent methodological 13These advances have the field of addiction neuroscience from broad descriptions 14 of altered reward processing toward increasingly granular accounts of the circuits, cellular populations, 15 molecular mechanisms, and behavioral processes that underwrite substance use disorders (SUDs) 16 (Venniro et al., 2020;Mathis et al., 2025a;Nestler, 2025). At the same time, the concept of addiction 17 itself has expanded from an exclusive focus on impact of psychotropic drugs to encapsulating 18 problematic behavioral patterns like gambling, sex, screen time, and food intake. This expansion raises 19 many important questions, including: What exactly defines addiction? Do all forms of addiction stem 20 of pathological patterns of activity within overlapping, or distinct, brain circuit mechanisms? This 21Research Topic was conceived at the intersection of these developments. As highlighted by the studies included in this special issue, new vistas in addiction research require the 77 field move beyond emphasizing effects on singular behavioral and neural endpoints. Food and drugs, 78 for example, engage overlapping motivational systems, but feeding is also embedded within metabolic 79 regulation and physiological homeostasis. Therefore, problematic eating behaviors necessarily 80 manifest in a manner that will have overlapping, and unique, behavioral and mechanistic underpinnings 81 relative to psychoactive drugs. It's important to acknowledge these domain specific nuances, as well 82 as that not every reward-based behavior necessarily leads to addiction. Indeed, true progress will likely 83 require a greater, field-wide acknowledgement of the complex interplay of environmental, cognitive, 84 neurochemical, and genetic predispositions that seed addiction in certain individuals. 85 86The contributions to this Research Topic highlight three complementary shifts that are increasingly 87 shaping addiction research: from static measures to dynamic trajectories, from isolated brain circuits 88 to interacting biological systems, and from substance-centered definitions to mechanistically informed 89 models of maladaptive behavior. 90 91The future of addiction research will not be defined solely by our ability to measure more molecules, 92 record more neurons, or quantify more behavioral dimensions. Its progress will depend on our ability 93 to use these technologies to ask better questions and improve our analysis and interpretation. 94Rethinking addiction therefore does not necessarily mean expanding its definition. It may instead mean 95 refining it: identifying when, why, and for whom a behavior becomes persistent, maladaptive, and 96 difficult to control. This conceptual refinement, supported by increasingly sophisticated technologies 97 and integrative approaches, may ultimately provide a stronger foundation for more precise diagnosis, 98 prevention, and treatment.
- Open Access
- 30 May 2026
- Published by Elsevier in Biological Psychiatry
Targeting Mu Opioid Receptor Neurons of the Habenula to Limit Naloxone Aversion
- 30 May 2026
- Published by Elsevier in Biological Psychiatry
Open AccessTargeting Mu Opioid Receptor Neurons of the Habenula to Limit Naloxone Aversion
- 1 April 2026
- Published by Springer Nature in Nature
- Vol. 652 (8112) , 1127-1128
Super-potent opioids could be safer-than-expected alternatives to conventional painkillers
- 1 April 2026
- Published by Springer Nature in Nature
- Vol. 652 (8112) , 1127-1128
Super-potent opioids could be safer-than-expected alternatives to conventional painkillers
- Open Access
IFNγ-associated immune–metabolic remodeling drives serotonin–kynurenine imbalance with cortical vulnerability in lupus-prone mice
Introduction: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a major clinical challenge, characterized by heterogeneous manifestations and the absence of reliable biomarkers. The mechanisms linking systemic autoimmunity to neuronal injury and neuropsychiatric symptoms remain poorly understood. Methods: Using the lupus-prone MRL/Lpr mouse model, we integrated systemic cytokine profiling, plasma neurofilament light chain (NfL), region-specific CNS cytokine mapping, cortical metabolomics, and behavioral analyses to dissect immune–metabolic–neuronal interactions. Results: Inflammation was dominated by a Th1 cytokine program, with interferon-gamma emerging as the central driver. Composite cytokine scores correlated strongly with plasma NfL, establishing an immune–neuronal injury axis. Region-resolved analyses revealed distinct CNS cytokine signatures, including selective hippocampal loss of interleukin-10 and IFNγ-dominated responses in the frontal cortex. Cortical metabolomics demonstrated diversion of tryptophan metabolism away from serotonin toward the kynurenine pathway, with increased quinolinic acid/kynurenic acid (QA/KA) ratio and upregulation of indoleamine 2,3-dioxygenase-1 ( Ido1 ) and kynurenine 3-monooxygenase ( Kmo ). NfL levels were negatively associated with serotonin and positively with 3-hydroxykynurenine and QA/KA, linking axonal damage to an excitotoxic metabolic environment. Importantly, cortical serotonin levels correlated with exploratory behavior, linking serotonergic depletion to anxiety-like phenotypes. Discussion: Together, these results delineate a cascade in which systemic IFNγ is associated with cortical metabolic reprogramming and neuronal vulnerability, bridging peripheral immune activation with serotonergic depletion, melatonin loss, axonal injury, and behavioral dysfunction. Translationally, combined blood or CSF monitoring of IFNγ, NfL, and kynurenine metabolites could represent a candidate biomarker framework for NPSLE. However, validation in independent patient cohorts will be essential, and therapeutic modulation of IDO1/KMO or serotonergic pathways remains an avenue for future investigation.
Open AccessIFNγ-associated immune–metabolic remodeling drives serotonin–kynurenine imbalance with cortical vulnerability in lupus-prone mice
Introduction: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a major clinical challenge, characterized by heterogeneous manifestations and the absence of reliable biomarkers. The mechanisms linking systemic autoimmunity to neuronal injury and neuropsychiatric symptoms remain poorly understood. Methods: Using the lupus-prone MRL/Lpr mouse model, we integrated systemic cytokine profiling, plasma neurofilament light chain (NfL), region-specific CNS cytokine mapping, cortical metabolomics, and behavioral analyses to dissect immune–metabolic–neuronal interactions. Results: Inflammation was dominated by a Th1 cytokine program, with interferon-gamma emerging as the central driver. Composite cytokine scores correlated strongly with plasma NfL, establishing an immune–neuronal injury axis. Region-resolved analyses revealed distinct CNS cytokine signatures, including selective hippocampal loss of interleukin-10 and IFNγ-dominated responses in the frontal cortex. Cortical metabolomics demonstrated diversion of tryptophan metabolism away from serotonin toward the kynurenine pathway, with increased quinolinic acid/kynurenic acid (QA/KA) ratio and upregulation of indoleamine 2,3-dioxygenase-1 ( Ido1 ) and kynurenine 3-monooxygenase ( Kmo ). NfL levels were negatively associated with serotonin and positively with 3-hydroxykynurenine and QA/KA, linking axonal damage to an excitotoxic metabolic environment. Importantly, cortical serotonin levels correlated with exploratory behavior, linking serotonergic depletion to anxiety-like phenotypes. Discussion: Together, these results delineate a cascade in which systemic IFNγ is associated with cortical metabolic reprogramming and neuronal vulnerability, bridging peripheral immune activation with serotonergic depletion, melatonin loss, axonal injury, and behavioral dysfunction. Translationally, combined blood or CSF monitoring of IFNγ, NfL, and kynurenine metabolites could represent a candidate biomarker framework for NPSLE. However, validation in independent patient cohorts will be essential, and therapeutic modulation of IDO1/KMO or serotonergic pathways remains an avenue for future investigation.
- Open Access
- 29 October 2025
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 19, 1697469
Incubation of social deficit during morphine abstinence in male mice using a novel unbiased and automatized method
Introduction: Opioid use disorder (OUD) is a chronic relapsing condition caused by prolonged opioid exposure, which triggers adaptive changes in the brain. These changes make it challenging to control or abstain from consuming, and significantly increase the risk of relapse. While the physical symptoms of withdrawal typically resolve within a few days, extended abstinence is frequently accompanied by the progressive development of emotional disturbances. Additionally, abstinent individuals often report social disengagement, or even social isolation that worsen the condition and participates in the development of comorbidities. These disturbances are similarly observed in murine models of opioid abstinence. Methods: However, traditional methods for assessing social deficits in rodents often rely on simplistic paradigms with limited behavioral metrics. Here, we utilized a well-established model of morphine administration followed by protracted abstinence, combined with the Live Mouse Tracker (LMT) system. Using the real-time video-based automated LMT system, we conducted longitudinal recordings of social behaviors over a 4-week period of morphine abstinence, during repeated social interaction sessions. Results: The use of this method, offering an unbiased and precise behavioral characterization of social investigation between freely-moving male mice, revealed that while motor and activity-related disruptions emerge and resolve quickly immediately following the onset of abstinence, social deficits progressively intensify over time, reaching their peak 3 weeks after the final morphine administration. Additionally, the LMT provided detailed insights into subtle behavioral changes throughout the course of abstinence and within individual but also that early deficits in explorations and social interactions might serve as predictor for the severity of the late social deficits. Discussion: These results point out the need to improve and implement unbiased tracking methods for a deeper and refined understanding of rodent behaviors modeling psychiatric conditions.
- 29 October 2025
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 19, 1697469
Open AccessIncubation of social deficit during morphine abstinence in male mice using a novel unbiased and automatized method
Introduction: Opioid use disorder (OUD) is a chronic relapsing condition caused by prolonged opioid exposure, which triggers adaptive changes in the brain. These changes make it challenging to control or abstain from consuming, and significantly increase the risk of relapse. While the physical symptoms of withdrawal typically resolve within a few days, extended abstinence is frequently accompanied by the progressive development of emotional disturbances. Additionally, abstinent individuals often report social disengagement, or even social isolation that worsen the condition and participates in the development of comorbidities. These disturbances are similarly observed in murine models of opioid abstinence. Methods: However, traditional methods for assessing social deficits in rodents often rely on simplistic paradigms with limited behavioral metrics. Here, we utilized a well-established model of morphine administration followed by protracted abstinence, combined with the Live Mouse Tracker (LMT) system. Using the real-time video-based automated LMT system, we conducted longitudinal recordings of social behaviors over a 4-week period of morphine abstinence, during repeated social interaction sessions. Results: The use of this method, offering an unbiased and precise behavioral characterization of social investigation between freely-moving male mice, revealed that while motor and activity-related disruptions emerge and resolve quickly immediately following the onset of abstinence, social deficits progressively intensify over time, reaching their peak 3 weeks after the final morphine administration. Additionally, the LMT provided detailed insights into subtle behavioral changes throughout the course of abstinence and within individual but also that early deficits in explorations and social interactions might serve as predictor for the severity of the late social deficits. Discussion: These results point out the need to improve and implement unbiased tracking methods for a deeper and refined understanding of rodent behaviors modeling psychiatric conditions.
- Open Access
Sex-divergent brain epigenetic reprogramming by chronic opioids
Opioid use disorder (OUD) is a chronic condition that exhibits sex differences in prevalence, symptoms and treatment. Yet, the epigenetic mechanisms underlying these differences remain largely unknown. Here, we investigated the nucleus accumbens, a key brain region in OUD, to define the multiomic consequences of chronic morphine exposure in male and female mice. We profiled DNA methylation, five histone post-translational modifications, and their transcriptional effects at bulk and cell-type-specific levels. Despite comparable tissue organization and neurophysiological responses to morphine, epigenetic adaptations occurred at highly sex-specific genomic loci. These adaptations nevertheless followed common mechanistic principles, acting at similar gene features and transcription factor binding sites across sexes. Strikingly, they converged on overlapping genes, biological functions, and co-expression modules, and partially recapitulated transcriptional signatures of OUD in men and women. Therefore, our findings uncover a profound epigenetic sex divergence that mediates convergent biological dysregulation, and highlight opportunities for developing improved therapeutic strategies tailored to sex-specific mechanisms.
Open AccessSex-divergent brain epigenetic reprogramming by chronic opioids
Opioid use disorder (OUD) is a chronic condition that exhibits sex differences in prevalence, symptoms and treatment. Yet, the epigenetic mechanisms underlying these differences remain largely unknown. Here, we investigated the nucleus accumbens, a key brain region in OUD, to define the multiomic consequences of chronic morphine exposure in male and female mice. We profiled DNA methylation, five histone post-translational modifications, and their transcriptional effects at bulk and cell-type-specific levels. Despite comparable tissue organization and neurophysiological responses to morphine, epigenetic adaptations occurred at highly sex-specific genomic loci. These adaptations nevertheless followed common mechanistic principles, acting at similar gene features and transcription factor binding sites across sexes. Strikingly, they converged on overlapping genes, biological functions, and co-expression modules, and partially recapitulated transcriptional signatures of OUD in men and women. Therefore, our findings uncover a profound epigenetic sex divergence that mediates convergent biological dysregulation, and highlight opportunities for developing improved therapeutic strategies tailored to sex-specific mechanisms.
- Top Cited Papers
- 27 October 2025
- Published by Springer Nature in Nature Reviews Neuroscience
- Vol. 26 (12) , 778-797
The neural circuits and signalling pathways of opioid use disorder
The increasing prevalence of opioid use disorder (OUD) represents an important global public health crisis, often referred to as the ‘opioid epidemic’. Opioids are known for their potent pain-relieving effects, but also have serious side effects, including OUD and respiratory depression, which can lead to fatal overdoses. To address this growing concern, we require a better understanding of the mechanisms underlying OUD, which typically begins with either medical or recreational opioid use and evolves into a complex and chronic brain disorder. In this Review, we highlight recent advances in our understanding of opioid receptors and the neural circuits in which they operate (including the broad network of circuits involved in reward and relief processing), focusing on the changes that follow long-term opioid exposure, abstinence and withdrawal. Additionally, we discuss recent findings that highlight the importance of the local cellular environment in shaping responses to these drugs. Overall, we aim to provide an updated overview of the field that may give us new insights into the multifaceted landscape of OUD.
- 27 October 2025
- Published by Springer Nature in Nature Reviews Neuroscience
- Vol. 26 (12) , 778-797
Top Cited PapersThe neural circuits and signalling pathways of opioid use disorder
The increasing prevalence of opioid use disorder (OUD) represents an important global public health crisis, often referred to as the ‘opioid epidemic’. Opioids are known for their potent pain-relieving effects, but also have serious side effects, including OUD and respiratory depression, which can lead to fatal overdoses. To address this growing concern, we require a better understanding of the mechanisms underlying OUD, which typically begins with either medical or recreational opioid use and evolves into a complex and chronic brain disorder. In this Review, we highlight recent advances in our understanding of opioid receptors and the neural circuits in which they operate (including the broad network of circuits involved in reward and relief processing), focusing on the changes that follow long-term opioid exposure, abstinence and withdrawal. Additionally, we discuss recent findings that highlight the importance of the local cellular environment in shaping responses to these drugs. Overall, we aim to provide an updated overview of the field that may give us new insights into the multifaceted landscape of OUD.
- Open Access
- 19 June 2025
- Published by Wiley in Addiction Biology
- Vol. 30 (6) , e70058
The GPR88 Agonist RTI‐122 Reduces Alcohol‐Related Motivation and Consumption
GPR88, an orphan G protein‐coupled receptor primarily expressed in the striatum, has emerged as a potential target for treating alcohol use disorder (AUD) due to its role in modulating reward and motivational pathways. In this study, we investigated the effects of the GPR88 agonist RTI‐122 on alcohol intake and motivation to self‐administer alcohol under different conditions. In mice, RTI‐122 reduced alcohol consumption in a two‐bottle choice paradigm, which was prevented by Gpr88 knockout, confirming a GPR88‐specific effect on the attenuation of alcohol drinking. In rats, RTI‐122 dose‐dependently reduced operant alcohol self‐administration and decreased motivation to self‐administer alcohol in progressive ratio tasks, regardless of whether the alcohol was adulterated with quinine or not. Additionally, a high dose of RTI‐122 reduced yohimbine‐induced reinstatement. Importantly, RTI‐122 did not affect water intake in mice or sucrose self‐administration in rats, indicating receptor‐ and reward‐specific modulation of alcohol intake. These findings suggest that RTI‐122, through GPR88 agonism, effectively reduces alcohol consumption and motivation across various contexts, positioning it as a promising lead for the development of new AUD treatments.
- 19 June 2025
- Published by Wiley in Addiction Biology
- Vol. 30 (6) , e70058
Open AccessThe GPR88 Agonist RTI‐122 Reduces Alcohol‐Related Motivation and Consumption
GPR88, an orphan G protein‐coupled receptor primarily expressed in the striatum, has emerged as a potential target for treating alcohol use disorder (AUD) due to its role in modulating reward and motivational pathways. In this study, we investigated the effects of the GPR88 agonist RTI‐122 on alcohol intake and motivation to self‐administer alcohol under different conditions. In mice, RTI‐122 reduced alcohol consumption in a two‐bottle choice paradigm, which was prevented by Gpr88 knockout, confirming a GPR88‐specific effect on the attenuation of alcohol drinking. In rats, RTI‐122 dose‐dependently reduced operant alcohol self‐administration and decreased motivation to self‐administer alcohol in progressive ratio tasks, regardless of whether the alcohol was adulterated with quinine or not. Additionally, a high dose of RTI‐122 reduced yohimbine‐induced reinstatement. Importantly, RTI‐122 did not affect water intake in mice or sucrose self‐administration in rats, indicating receptor‐ and reward‐specific modulation of alcohol intake. These findings suggest that RTI‐122, through GPR88 agonism, effectively reduces alcohol consumption and motivation across various contexts, positioning it as a promising lead for the development of new AUD treatments.